Speaking on the Lancet study which says Hydroxychloroquine (HCQ) raises chances of death and irregular heart rhythm, Indian Council of Medical Research (ICMR), Director General, Dr Balram Bhargava.
Even as the World Health Organisation (WHO) halted the hydroxychloroquine arm of its COVID-19 drug trials on Monday, the Indian Council of Medical Research (ICMR) today said that there were no major side-effects of the malaria drug in the studies in India.
“From just one COVID-19 testing lab in Pune to 430 public labs and 182 private labs across the nation, India has significantly expanded its testing in the last 3 months,” said ICMR
As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India's top medical body has said the human trials of COVID-19 vaccine may begin at least in six months.
The Indian Council of Medical Research on Monday said that India developed an Intelligent Testing Strategy to remain 'ahead of the virus' by developing testing infrastructure that is laboratories and other means of testing.
Indian Council of Medical Research (ICMR) approved COVID-19 negative certificates are required to directly go to home without testing in Goa.
A revised government advisory on Friday recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection-related activities.
Starting with less than 100 COVID-19 tests per day just two months ago, a 1000-fold increase in just 60 days was made possible by dedicated teams from research institutions, medical colleges, testing laboratories, ministries, airlines and postal services working together, the Indian Council of Medical Research (ICMR) said in a statement.
Invasive technique should not be adopted for forensic autopsy in COVID-19 death cases as mortuary staff are exposed to potentially dangerous health risks due to organ fluids and secretions even after taking the highest precautions
The survival of coronavirus gradually decreases with time in a dead body, as per scientific literature till now, though there is no specific duration to declare a body as non-infective, the ICMR said on Tuesday.
Countries across the world are vying to create a vaccine for COVID-19. India too has entered the race to develop a vaccine for coronavirus. The Indian Council Medical Research (ICMR) and Bharat Biotech International Limited have partnered for the development of a "fully indigenous vaccine".
COVID-19 would be recorded as an "underlying cause of death" when leading to pneumonia, cardiac injury and clotting in the bloodstream, among others, according to the guidance issued by ICMR for appropriate recording of deaths due to the disease in India.
The vaccine will be developed using the virus strain isolated at the ICMR's National Institute of Virology (NIV), Pune.
The council has set a target of carrying out 1 lakh tests across the country per day. As coronavirus cases in the country have crossed the 50,000 mark. It is the need of the hour to widen testing across the length and breadth of the country.
The number of RT-PCR test for detection of COVID-19 conducted in India crossed the one million mark on Saturday, ICMR officials said, as the total novel coronavirus infections rose to 37,776.
The government said that the ICMR tried to source the rapid body testing kits directly from China, adding that several issues hindered the effort to eliminate the Indian intermediaries from the deal
The Indian Council of Medical Research (ICMR) on Tuesday revised advisory to state governments regarding Rapid Antibody Blood tests. ICMR has written to them to stop using Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics kits.
Kerala Health Minister, KK Shailaja said that they are waiting for good kits from Indian Council of Medical Research (ICMR) in wake of coronavirus outbreak.
A day after advising states not to use the newly distributed rapid testing kits to detect coronavirus infection for the next two days, the ICMR issued a protocol reiterating their usage for surveillance purpose while stating that RT-PCR tests must be continued vigorously as the principal diagnostic test for COVID-19.
A city-based private hospital has been given the nod by the Indian Council of Medical Research to conduct clinical trials on COVID-19 patients using plasma therapy.
Top News
Latest News
